Patent details

Basic Information

Publication number:

EP1109536

PCT Application Number:

PCT/US/99/18718

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999437338

PCT Publication Number:

WO/00/13672

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NEW SOLID DOSE FORM OF NANOPARTICULATE NAPROXEN

French Title of Invention:

NOUVELLE FORME DE NAPROXENE NANOPARTICULAIRE EN DOSE SOLIDE

German Title of Invention:

NEUE FESTE DOSISFORM ENTHALTEND NANOPARTIKELNAPROXEN

SPC Number:

Dates

Filing date:

19/08/1999

Grant date:

03/07/2002

EP Publication Date:

03/07/2002

PCT Publication Date:

16/03/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/06/2001

EP B1 Publication Date:

03/07/2002

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/08/2002

Expiration date:

19/08/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/08/1999

 

 

Name:

Elan Pharma International Limited

Address:

WIL House, Shannon Business Park, Shannon, Clare County, Ireland (IE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

17/07/2002

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WEI Linden

Address:

United States (US)

2

Name:

JAIN Rajeev, A.

Address:

United States (US)

3

Name:

SWANSON Jon

Address:

United States (US)

Priority

Priority Number:

148332

Priority Date:

04/09/1998

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/20;

Filing date	Document type	Number of pages